Ovid Therapeutics (OVID) Receivables - Other (2016 - 2022)
Ovid Therapeutics (OVID) posted Receivables - Other of $750000.0 for Q1 2022, down 26.74% on a QoQ basis from $1.0 million in Q1 2021, and down 26.74% year-over-year from $1.0 million in Q1 2021.
Ovid Therapeutics (OVID) Receivables - Other (2016 - 2022) Analysis & Trends
Ovid Therapeutics' Receivables - Other history runs 6 years deep, the most recent figure standing at $750000.0 for Q1 2022.
- Quarterly Receivables - Other fell 26.74% year-over-year to $750000.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $750000.0 (down 26.74% YoY) and the FY2020 annual result came in at $141763.0, down 87.47% from the prior year.
- Receivables - Other was $750000.0 for Q1 2022 at Ovid Therapeutics, down from $1.0 million in the prior quarter.
- Across five years, Receivables - Other topped out at $1.6 million in Q2 2019 and bottomed at $141763.0 in Q4 2020.
- A 5-year average of $808531.9 and a median of $699497.5 in 2020 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2020 — Receivables - Other slumped 87.47% — and 2021, when it soared 173.56%.
- Ovid Therapeutics' Receivables - Other stood at $600104.0 in 2018, then soared by 88.49% to $1.1 million in 2019, then slumped by 87.47% to $141763.0 in 2020, then surged by 622.18% to $1.0 million in 2021, then fell by 26.74% to $750000.0 in 2022.
- Business Quant data shows OVID's Receivables - Other at $750000.0 in Q1 2022, $1.0 million in Q1 2021, and $141763.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 750,000.00 |
| Mar 31, 2022 | 750,000.00 |
| Mar 31, 2021 | 1.02 Mn |
| Mar 31, 2021 | 1.02 Mn |
| Dec 31, 2020 | 141,763.00 |
| Dec 31, 2020 | 141,763.00 |
| Sep 30, 2020 | 648,995.00 |
| Sep 30, 2020 | 648,995.00 |
| Jun 30, 2020 | 563,182.00 |
| Jun 30, 2020 | 563,182.00 |
| Mar 31, 2020 | 374,252.00 |
| Mar 31, 2020 | 374,252.00 |
| Dec 31, 2019 | 1.13 Mn |
| Dec 31, 2019 | 1.13 Mn |
| Jun 30, 2019 | 1.59 Mn |
| Jun 30, 2019 | 1.59 Mn |
| Mar 31, 2019 | 1.26 Mn |
| Mar 31, 2019 | 1.26 Mn |
| Dec 31, 2018 | 600,104.00 |
| Dec 31, 2018 | 600,104.00 |